Boehringer Ingelheim
Boehringer Ingelheim, a leading name in the pharmaceutical preparation manufacturing industry, is headquartered in Ingelheim am Rhein, Germany. Founded in 1885, the company has established a strong global presence, with significant operations across Europe, North America, and Asia.
Specialising in prescription medicines, animal health, and biopharmaceutical contract manufacturing, Boehringer Ingelheim is renowned for its innovative therapies that address unmet medical needs. The company’s commitment to research and development has led to numerous breakthroughs, particularly in respiratory diseases, oncology, and diabetes care.
With a robust portfolio of unique products and a reputation for quality, Boehringer Ingelheim consistently ranks among the top pharmaceutical companies worldwide, reflecting its dedication to improving health and well-being across diverse populations.
+2 vs industry average
Boehringer Ingelheim’s score of 42 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Boehringer Ingelheim?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Boehringer Ingelheim's reported carbon emissions
Boehringer Ingelheim, a pharmaceutical preparation manufacturer headquartered in Germany, is committed to reducing its environmental impact. For the 2024 reporting year, the company reported Scope 1 emissions of approximately 274,000,000 kg CO2e and Scope 2 emissions of about 64,000,000 kg CO2e.
In 2023, Boehringer Ingelheim's total emissions, encompassing Scope 1, 2, and 3, amounted to approximately 4,365,000,000 kg CO2e. This included Scope 1 emissions of approximately 295,000,000 kg CO2e and Scope 2 emissions of approximately 66,000,000 kg CO2e. Scope 3 emissions for the same year were approximately 4,043,000,000 kg CO2e.
The company has established Science Based Targets initiative (SBTi) approved commitments. Boehringer Ingelheim aims to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 58.9% by 2030, using 2019 as the base year. Furthermore, the company has committed to a 27.5% reduction in absolute Scope 3 emissions by 2030, focusing on categories including purchased goods and services, capital goods, fuel and energy-related activities, upstream transportation and distribution, and use of sold products. These targets are consistent with limiting global warming to 1.5°C.
Emissions data is cascaded from Boehringer Ingelheim GmbH, its parent organisation.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Boehringer Ingelheim’s Climate Goals (2030 & 2050)
3 goals2030
58.9% reduction in Scope 2
Boehringer Ingelheim commits to reduce absolute scope 1 and 2 GHG emissions 58.9% by 2030 from a 2019 base year.* Boehringer Ingelheim also…
2030
58.9% reduction in Scope 1
Boehringer Ingelheim commits to reduce absolute scope 1 and 2 GHG emissions 58.9% by 2030 from a 2019 base year.* Boehringer Ingelheim also…
2030
27.5% reduction in scope 3 total
Boehringer Ingelheim commits to reduce absolute scope 1 and 2 GHG emissions 58.9% by 2030 from a 2019 base year.* Boehringer Ingelheim also…
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
Inherited from C.H. Boehringer Sohn AG & Co. KGThe Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsFrequently asked questions
Common questions about Boehringer Ingelheim’s sustainability data and climate commitments
Data year: 2024
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project